Huff James Warren's Form 4 filing
Reata Pharmaceuticals Inc (RETA) · filed Mar 3, 2023
- Accession no.
- 0001209191-23-015713
- Filed
- Mar 3, 2023
- Trade date
- Mar 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.41M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huff James WarrenCIK 0001662411 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Class A common stock | CConversionAcquired | +75,000 | – | – | 111,158 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −8,104 | $81.49 | −$660,394.96 | 103,054 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −12,132 | $82.20 | −$997,250.4 | 90,922 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −9,660 | $83.31 | −$804,774.6 | 81,262 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −7,439 | $84.33 | −$627,330.87 | 73,823 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −6,395 | $85.25 | −$545,173.75 | 67,428 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −3,475 | $86.44 | −$300,379 | 63,953 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −4,034 | $87.61 | −$353,418.74 | 59,919 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −12,826 | $88.59 | −$1,136,255.34 | 47,093 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −5,742 | $89.49 | −$513,851.58 | 41,351 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −4,623 | $90.57 | −$418,705.11 | 36,728 | Direct | |
| Mar 2, 2023 | Class A common stock | SSaleDisposed | −570 | $91.12 | −$51,938.4 | 36,158 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Class A common stock | CConversionDisposed | −75,000 | – | – | 212,903 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.